Quantum Leap for Quantum Dots

Courtesy of Evident Technologies High-resolution fluorescence micro-scopy has revolutionized cell biology, most agree. But the revolution has not come without sacrifice. The enabling equipment--excitation sources, optics, and photodetection hardware--is expensive, and the necessary fluorescent dyes and proteins are relatively photo-unstable. Moreover, because of overlapping absorption and emission profiles, traditional fluorescent markers support only limited multiplexing; that is, researcher

Written byJeffrey Perkel
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

High-resolution fluorescence micro-scopy has revolutionized cell biology, most agree. But the revolution has not come without sacrifice. The enabling equipment--excitation sources, optics, and photodetection hardware--is expensive, and the necessary fluorescent dyes and proteins are relatively photo-unstable. Moreover, because of overlapping absorption and emission profiles, traditional fluorescent markers support only limited multiplexing; that is, researchers can stain cells for only three or four proteins at once.

Recent evidence, however, suggests change is afoot in the form of fluorescent semiconductor nanocrystals or "quantum dots." Containing several hundred to a few thousand atoms, quantum dots exhibit several desirable properties, from a biological applications standpoint. They are highly photostable, fluorescing for hours without photobleaching. Also, they are tunable, the emission spectrum depending on the crystals' diameter. With narrow emission profiles and broad excitation profiles, the dots provide for high levels of multiplexing, yet all can be excited using a single light source.

QUANTUM ROADBLOCKS ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies